Volume 12 , Issue 4 , December 2022 , Pages 339-344
Soma Tahir Abdulla 1 ; Tahir Abdulla Hussein 1 ; Maryam Bakir Mahmood 2
1 Sulaimani Maternity Teaching Hospital, Sulaimani, Kurdistan Region, Iraq.
2 Sulaimani Maternity Teaching Hospital, College of Medicine, University of Sulaimani, Kurdistan Region, Iraq.
Background
Staging laparotomy can provide optimal care for gynecological malignancies by avoiding over treatment and
under treatment.
Objectives
The aim was to explore the difference between surgical and clinical disease staging of gynecological
malignancies.
Patients and Methods
A retrospective observational study was performed on 30 women who were operated on for gynecological
malignancies and were admitted to the Sulaimani Maternity Teaching Hospital from January 2019 to December
2020. Inclusion criteria included women diagnosed with gynecological malignancies before staging laparotomy.
However, exclusion criteria included previous abdominal surgeries for other gynecological malignancies. In
addition, demographic features, previous diagnostic methods, and intraoperative staging were recorded.
Results
The mean±SD (standard deviation) age was 51.8±14.9 years (range, 12 to 72), and the majority (56.7%) was
between 50-69 years. The mean±SD of patients’ gravida and para were 4.5±3.5 (range, 0-12) and 3.4±2.8
(range, 0-8), respectively. In addition, 20% of women had a personal history (13.3%) of tumors or familial
history (6.7%)—most women (50%) presented with abnormal vaginal bleeding, either postmenopausal or
menstrual abnormalities. Most women with endometrial tumors (50%) had been afflicted with adenocarcinoma
(endometrioid type); however, the most common types of ovarian tumors were granulosa cell tumor, papillary
serous adenocarcinoma, and malignant ovarian dysgerminoma in 10%, 10%, and 6.7%, respectively. The
association between clinical staging and staging laparotomy was significant. There was a 60% upgrade from
a lower stage to a higher stage; however, downgrading was only 3.3%.